Report of Foreign Issuer (6-k)
June 15 2017 - 04:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act
of 1934
For the month of June 2017
Commission File Number: 001-37643
KITOV PHARMACEUTICALS HOLDINGS
LTD.
(Translation of registrant's name into
English)
One
Azrieli Center, Round Tower, 23
rd
Floor, Tel Aviv 6701101, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Kitov Pharmaceuticals Holdings Ltd. (the
“Company” or the “Registrant”) is announcing that on June 15, 2017 its majority owned consolidated subsidiary,
TyrNovo Ltd., issued a press release, “
TyrNovo Ltd. to Participate in 2017 BIO International Convention
”, which
is attached hereto as Exhibit 99.1. In connection with the above, the Company also made available an updated Company Presentation
on its website. A copy of the updated Company Presentation is attached hereto as Exhibit 99.2 and may be viewed in the Investor
Relations section of the Registrant’s website at
www.kitovpharma.com
.
Attached hereto are the following exhibits:
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
KITOV PHARMACEUTICALS HOLDINGS LTD.
|
|
|
June 15, 2017
|
By:
|
/s/ Avraham Ben-Tzvi
|
|
|
Avraham Ben-Tzvi
|
|
|
Company Secretary
|
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Feb 2024 to Mar 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Mar 2023 to Mar 2024